Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial

Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial

Authors of this article:

Nikhil Chauhan ¹ ;   Janet Bukovcan ¹ ;   Eveline Boucher ¹ ;   David Cosgrove ² ;   Julien Edeline ³ ;   Bonnie Hamilton ¹ ;   Laura Kulik ⁴ ;   Fayaz Master ¹ ;   Riad Salem ^{5, 6, 7}